MOREPEN LABORATORIES
Back to Balance Sheet
|
MOREPEN LABORATORIES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹501 Cr | ₹402 Cr | ₹321 Cr | ₹456 Cr | ₹404 Cr |
What is the latest Total Current Liabilities ratio of MOREPEN LABORATORIES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹501 Cr |
| Mar2024 | ₹402 Cr |
| Mar2023 | ₹321 Cr |
| Mar2022 | ₹456 Cr |
| Mar2021 | ₹404 Cr |
How is Total Current Liabilities of MOREPEN LABORATORIES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹501 Cr | 24.53 | |
| Mar2024 | ₹402 Cr | 25.18 | |
| Mar2023 | ₹321 Cr | -29.64 | |
| Mar2022 | ₹456 Cr | 13.04 | |
| Mar2021 | ₹404 Cr | - | |
Compare Total Current Liabilities of peers of MOREPEN LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MOREPEN LABORATORIES | ₹2,154.2 Cr | 3.6% | 10.5% | -27.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹413,753.0 Cr | 1.5% | 5.5% | 0.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,032.0 Cr | 2.3% | 3.6% | 7.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹143,426.0 Cr | -0.5% | 5.3% | 40.2% | Stock Analytics | |
| CIPLA | ₹108,360.0 Cr | -1.1% | -2.2% | -8.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,859.0 Cr | 0.9% | 5.2% | 7% | Stock Analytics | |
MOREPEN LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MOREPEN LABORATORIES | 3.6% |
10.5% |
-27.1% |
| SENSEX | 0.2% |
1.1% |
8.8% |
You may also like the below Video Courses